1 TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3 Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
4 Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
5 Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
6 Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
7 Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA.
8 Immunai, New York, NY, USA.
9 Department of Surgery, University of Rochester, Rochester, NY, USA.
10 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
11 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
12 Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
13 Department of Surgery, Washington University in St Louis, St Louis, MO, USA.
14 Moffitt Cancer Center, Tampa, FL, USA.
15 AstraZeneca, Gaithersburg, MD, USA.
16 Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA.
17 Novartis Pharma, Basel, Switzerland.
18 Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
19 Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
20 Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
21 Department of Pathology, University of California, San Francisco, CA, USA.
22 Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.
23 Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
24 Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
25 TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org.
26 TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.
27 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
28 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.